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Graeme WistowAbstract
Crystallins are the abundant, long-lived proteins of the eye lens. The major human crystallins belong to two
different superfamilies: the small heat-shock proteins (α-crystallins) and the βγ-crystallins. During evolution, other
proteins have sometimes been recruited as crystallins to modify the properties of the lens. In the developing
human lens, the enzyme betaine-homocysteine methyltransferase serves such a role. Evolutionary modification has
also resulted in loss of expression of some human crystallin genes or of specific splice forms. Crystallin organization
is essential for lens transparency and mutations; even minor changes to surface residues can cause cataract and loss
of vision.
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Crystallin is a functional term that originated as a de-
scription of the highly abundant soluble proteins of the
‘crystalline’ (clear) vertebrate eye lens [1,2]. Crystallins
fill the hugely elongated, terminally differentiated fiber
cells of the lens and must survive without turnover
throughout life while maintaining transparency and the
molecular organization required for the refractive prop-
erties of the lens. As such, the complement of crystallins
in the lens has been peculiarly sensitive to evolutionary
pressures and has shown remarkable adaptation in dif-
ferent vertebrate lineages [1]. As a result, some crystal-
lins have very restricted distributions among species.
However, there is a core set of three originally identified
classes, the α-, β- and γ-crystallins, that must have arisen
in early aquatic ancestors, are widespread among verte-
brates, and account for most of the protein content of
the human lens. These three classes were defined mainly
by the sizes of oligomers they form, from very large
α-crystallin multimers (on the order of 500 kDa), through
dimer- to octamer-sized β-crystallins (approximately 45 to
180 kDa) to γ-crystallin monomers (20 kDa) [3]. Once
sequence data were obtained, it became clear that the
multimeric β- and monomeric γ-crystallins are in fact part
of the same βγ-crystallin superfamily. Although crystallins
were originally identified in the lens, they also have rolesCorrespondence: graeme@helix.nih.gov
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reproduction in any medium, provided the orin other tissues and have superfamily relationships with
other proteins. Indeed, throughout evolution, crystallins
seem to have been recruited from existing proteins whose
structure and other properties happened to suit them for
the new role in lens [4].
By analogy to the lens, “crystallin” has also been used
to describe abundant soluble proteins in the cornea,
another transparent tissue [5-7]. However this review
will focus only the human genes for proteins that are
highly abundant in the lens and have crystallin as part
of a HUGO Gene Nomenclature Committee (HGNC)
designation or a widely used name.
A useful resource to search for expressed sequence
tag (EST) data for crystallins (and other eye-expressed
proteins) is NEIBank (http://neibank.nei.nih.gov) [8]
and the accompanying eye-centric genome browser,
EyeBrowse (http://eyebrowse.cit.nih.gov/) which displays
expression and disease gene information for eye genes
of human and several other species. Details of gene
organization and splice patterns described in this review
can be conveniently viewed using EyeBrowse or the
original UCSC browser (http://genome.ucsc.edu/).CRYAA and CRYAB: genes for α-crystallins
In humans (and apparently most terrestrial vertebrates)
there are two α-crystallin genes, CRYAA and CRYAB,
encoding αA- and αB-crystallins [2,9]. They are located
in different chromosomes (21 and 11), but they are
closely related in sequence and gene structure and are
clearly the result of an ancient gene duplication. BothThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Exon/intron structure of mammalian genes for α-, β- and γ-crystallins. Exons are shown as boxes with ORF in thicker boxes. CRYB
genes coding for β-crystallins vary in 50-exon structure. The exons encoding the four structural motifs of the β-crystallin and γ-crystallin proteins
are indicated by 1, 2, 3, and 4. Some mammals have an alternatively spliced exon in the first intron of CRYAA, but in humans this is a pseudoexon.
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They have open reading frames (ORFs) of 173 (αA) and
175 codons (αB), corresponding to subunit sizes of
approximately 20 kDa, and the two proteins are 54%
identical in sequence. Ancestrally, the gene for αA-
crystallin had three exons, and this is reflected in many
species from fish to birds. However, during the evolution
of the mammalian lineage, there was an innovation with
the addition of an alternatively spliced exon, giving riseFigure 2 Phylogenetic tree of the human sHSP gene family. Sequence
aligned and neighbor-joining trees were constructed using MEGA4 [15].to a larger protein product (αAins) [10]. The ‘insert
exon’ is retained in many species, particularly rodents.
In primates, this alternative splice form was abandoned,
but the remnants of the insert exon remain in human
CRYAA as a pseudoexon [11]. While the sequence is no
longer spliced into mature mRNA, it is largely intact,
raising the interesting possibility that mutation could
restore splicing and perhaps lead to a novel cataracto-
genic defect.s were extracted from the UCSC web browser. Translated ORFs were
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α-crystallins belong to the superfamily of small heat-shock
proteins (sHSP) produced by even older duplications [12]
(Figure 2). In humans, there are ten genes for sHSPs
[13,14], and CRYAA and CRYAB also have the alternative
systematic (but not widely used) names HSPB4 and 5. The
tenth member has the HUGO name ODF1 [13]. Since the
α-crystallins are the archetypes of the superfamily, the
core-conserved region of the sequence for all these pro-
teins is referred to as the α-crystallin domain [9]. Indeed,
two of the non-crystallin members of this superfamily,
HSPB6 and HSPB9, have ‘alpha-crystallin-related’ as part
of their HUGO designation. Although the two α-crystallin
genes are not themselves linked, CRYAB is located
head-to-head (adjacent 50 regions, transcribed in opposite
directions) with the HSPB2 gene.
Functional implications
The relationship with sHSPs is not merely of evolution-
ary interest: αB-crystallin is a functional, stress-induced
sHSP and is expressed in many tissues, notably muscle,
sometimes at high levels (although not as high as in
lens) [9]. In contrast, αA-crystallin is much more
restricted to lens (although it has been found at low
levels elsewhere, particularly in retina [16]) and may
have evolved to specialize for the lens role, leaving the
major sHSP role to αB-crystallin. This illustrates an evo-
lutionary process in which a protein may acquire more
than one role (for example, both sHSP and crystallin); if
gene duplication then occurs, selection can lead to one
or both copies of the gene specializing for one of the ori-
ginal functions [4].
A primary function of any crystallin is to contribute to
the transparency and refractive power of the lens. How-
ever, other properties may also be important. In the case
of the α-crystallins, the chaperone-like functions of the
sHSPs have clear implications for roles in preventing ag-
gregation of misfolded proteins with obvious benefits to
lens transparency [9]. They may also have important
interactions with other cellular components, including
cytoskeleton, which is of major importance in the highly
elongated lens fiber cells [17].
Since CRYAB is now well known as a functional sHSP,
there has been a tendency to extend this functionality to
other crystallins when they are found in unexpected
places. It is important to recognize that only CRYAA and
CRYAB belong to the sHSP superfamily, and that func-
tional roles for other crystallins are only slowly emerging.
Cataractogenic mutations
Several cataract-causing mutations have been identified
in human α-crystallins. For CRYAA, three dominant cat-
aractogenic mutations are known which involve substi-
tution of one of two surface arginine residues: R49C[18], R116C [19] and R116H [20]. Other mutants in-
clude a recessive nonsense mutation which essentially
eliminates the ORF, W9X [21] and ΔY118 [22].
For CRYAB, some dominant mutations cause cataract
which is also associated with myofibrillar myopathy,
reflecting the role of the gene in muscle [9]. Three of
these involve truncations of the ORF: Δ464CT [23],
Q151X [23], and Δ60C [24], while one other, R120G
[25], involves substitution of a surface arginine. In con-
trast, another deletion/truncation mutation, Δ450A, is
only associated with posterior polar cataract [26]. An-
other congenital cataract in a Chinese study was identi-
fied with R69C [22].
Genes for β- and γ-crystallins
Domains and exons
These two families are evolutionarily related but are also
distinct (Figure 3). They share common core protein
structures, with two similar domains, each composed of
two characteristic-modified Greek key motifs. β-crystallins
may also have N- and/or C-terminal extensions, exhibit
greater structural flexibility in domain interactions, and
form multimers, while γ-crystallins are strict monomers
[1,2,27]. The two families also have distinct gene struc-
tures. In the genes for β-crystallins, each of the four struc-
tural motifs is encoded in a separate exon, while in (most)
γ-crystallin genes, the ‘intra-domain’ introns are missing
so that each domain is coded in a single exon (Figure 1).
Genes for β-crystallin also have variable numbers of 50
exons which account for N-terminal protein extensions
and which may include a non-coding first exon.
CRYB genes
This multigene family has ancient origins in vertebrates,
and indeed the six human genes have clear orthologs
in fish [28]. β-crystallins are subdivided into acidic (A)
and basic (B) subunits, encoded in CRYBA(1,2,4) and
CRYBB(1,2,3) genes. Unlike the α-crystallins, four of the
β-crystallin genes, arranged as two pairs, are close to-
gether on Chr 22 (Table 1, Figure 4).
CRYBA1
This single gene encodes two of the polypeptides that
were originally identified by protein analysis of mamma-
lian lenses, βA1- and βA3-crystallins, through the use of
alternative ORF start sites [29]. CRYBA1 is 7.6 kb long
with six exons and is found on Chr 17, separated from
other crystallin genes.
Cataractogenic mutations Inherited cataracts are sur-
prisingly frequently associated with splicing defects at
end of exon 3 in this gene that probably lead to exon
skipping. These are IVS3+1G>A [30], IVS3+1 G>C [31],
IVS3+1 G>T [32], and IVS3+2 T>G [33] with similar
Figure 3 Phylogenetic tree of the human βγ-crystallin gene superfamily. Sequences were extracted from the UCSC web browser. Translated
ORFs were aligned and neighbor-joining trees were constructed as in Figure 2. AIM1, AIML, and CRYBG3 contain internal repeats corresponding to
three β-crystallin-like genes in addition to regions not related to crystallin genes. For simplicity, the third, most highly conserved crystallin repeat
from each gene was used for this alignment (designated AIM1cter, etc.).
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(ΔG91) is the result of a 3-bp deletion of the codon for a
highly conserved glycine required for normal protein
folding [34]. Work in mice has revealed a role for βA3/
A1-crystallin in retinal astrocyte function [35], but so
far, it does not appear that astrocyte-related defects are
associated with the human cataract mutations.
CRYBA2
This gene is also separated from other β-crystallin genes,
being located on Chr 2, but is fairly close to a cluster of
genes encoding γ-crystallins (Figure 4). The CRYBA2 gene
is 3.2 kb long and the major form has five exons. A variant
transcript in which the first intron is included is also
represented by several cDNA clones; however, since the
ORF starts in exon 2, there is no difference in predicted
protein product. No human cataract mutants have yet
been identified in this gene. Although cDNAs from this
gene are abundant in an adult human lens cDNA library
[36] for some time, it seemed that no protein for βA2-
crystallin was expressed in human lens (in contrast to bo-
vine and rodent lens in which the orthologous protein was
quite abundant. Subsequently, human βA2-crystallin was
detected in the lens cortex but at relatively low levels [37],
suggesting that translation of the mRNA may be inefficient.CRYBA4
CRYBA4 is part of a cluster of β-crystallin genes
that spans about 1.5 Mbp on Chr 22. The general
organization of this cluster is conserved in several spe-
cies, including chicken. This raises the possibility that
linkage is maintained for functional reasons, perhaps
for coordinated expression, but this has not been deter-
mined. Indeed, CRYBA4 is located head-to-head with
CRYBB1 (transcribed in opposite directions), a linkage
which is found in chicken [38] and is even present in
zebrafish (Danio rerio). CRYBA4 has seven exons
spread over 8.7 kb.Cataractogenic mutations Three coding sequence
single-base transitions are associated with human catar-
acts. The F94S mutation gives rise to a dominant lamellar
cataract [39]; L69P is associated with microphthalmia with
cataract [39], and G64W is associated with congenital
cataract and microcornea [40].CRYBB1
The gene for βB1-crystallin is an 18.6 kb gene with 6
exons, a structure common to all three of the genes for
βB-crystallins and CRYBA4.

























Gene/protein names and chromosome locations are shown. Genes/proteins in
bold type are expressed at relatively high levels similar to orthologs in other
mammals. Those in normal type seem to have reduced or no expression in
human lens. Some are designated pseudogenes. The proposed crystallin
designation for betaine-homocysteine methyltransferase (BHMT), ψ, does not
imply pseudogene status.
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ocular development defects are associated with CRYBB1.
Both dominant pulverulent (G220X) [41] and recessive
nuclear (ΔG168) [42] cataracts have been associated
with this gene. Autosomal dominant cataracts inFigure 4 Clustering of crystallin genes. Gaps, indicated by approximate
with arrows (dotted for pseudogenes).Chinese families are associated with Q223X [43], R233H
[44], and S228P [45]. Other mutants, X253R [46] and
S129R [47], are associated with both congenital cataract
and microcornea.CRYBB2 and CRYBB2P1
CRYBB2 is a 12.2 kb, six-exon gene close to CRYBB3 in
the Chr 22 cluster. There is a partial pseudogene copy
CRYBB2P1 located about 250 kb away in the same
cluster.Cataractogenic mutations A nonsense mutation
(Q155X) associated with dominant cerulean (blue and
white opacities) cataract has been identified in several
different populations [48-51]. It has been proposed
that this mutation results from independent gene conver-
sion events between CRYBB2 and CRYBB2P1 [50,51].
However, the close similarity of gene and pseudogene
sequences also raises the possibility of mispriming or the
generation of chimeras in genomic PCR. A recent note
describes a lack of specificity in primer sets used to
identify CRYBB2 mutants in another study [52,53], em-
phasizing the need for care in interpretation of results for
this gene. Several other mutants have been reported
including A2V (a surprisingly conservative change) [54],
V146M and I21N [44], R188H [55] and S143F [56].CRYBB3
CRYBB3 is located about 25 kb 50 to CRYBB2 in the
same orientation with no intervening genes. This linkage
is conserved in chicken (where the separation is only
about 2 kb), but not in zebrafish. The gene is 7.5 kb long
with six exons.Cataractogenic mutations A recessive nuclear cataract
is associated with a G165R mutation in CRYBB3 that
likely interferes with normal folding of the protein [57].sizes, contain non-crystallin genes. Gene orientations are indicated
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In most mammals, there are eight genes for γ-crystallins
[1,2,28,58]. Six encode a group of closely related pro-
teins, γA-F, that are typically expressed early in develop-
ment and therefore contribute mainly to the densest,
central region of the lens, the lens nucleus. The other
two members of the family, γS and γN, are more diver-
gent in sequence, and their genes are located in different
chromosomes (Table 1). All eight of these genes are
expressed in the mouse lens; however, in humans, two of
them are designated pseudogenes, another is effectively
a pseudogene, and two others are expressed at relatively
low levels in lens, suggesting that they too are in the
process of evolutionary loss [28,59].
CRYGA-CRYGFP
These genes form a cluster in most mammals, and in
the human genome, the orthologous genes and pseudo-
genes are clustered on Chr 2q (Figure 4). Unlike the
β-crystallins, these γ-crystallins do not have orthologs in
non-mammalian vertebrates; fish in particular have a
large number of γM proteins that do not group with
the mammalian proteins in phylogenetic analysis [28].
γ-crystallins appear to be highly specialized for the dense
packing of the lens nucleus and for the creation of high
refractive index, relatively inflexible lenses. This probably
explains the trend for loss of γ-crystallins in the accom-
modating lenses of primates, in birds, and in other spe-
cies such as guinea pig (Cavia porcellus) [60].
The genes all have three exons (Figure 1) and are typ-
ically 2 to 4 kb in length. The cluster clearly arose by
gene duplication. In humans, CRYGEP and CRYGFP are
pseudogenes with no evidence of expression [57]. For
this reason, they are not represented as genes in human
genome builds or on most browsers. This is unfortunate
since the genes are still largely intact and have at least
the potential for involvement in gene conversion with
active genes or even reactivation. Indeed, reactivation of
CRYGEP was at one time considered as the basis for a
human cataract, although this later proved not to be the
case [61]. Five of the clustered CRYG genes are arranged
sequentially: CRYGA, B, C, D, and EP, within about 40
kb in the human genome (Figure 4). CRYGFP, despite its
close similarity to CRYGEP, lies about 1 Mbp 50 to
CRYGA.
cDNA and proteomics analyses show that most of the
transcripts and proteins arising from this cluster in
humans come only from CRYGC and CRYGD, with the
latter being predominant [36,62,63]. This is reflected in
known cataract mutations in γ-crystallin genes.
Cataractogenic mutations In CRYGC, two mutations
leading to single amino acid substitutions of surface resi-
dues, T5P [58] and R168P [64], and a frame-shifting 5bp duplication in exon 2 (corresponding to the N-
terminal domain of the protein) [65], all cause cataract.
In CRYGD, five mutations leading to single amino acid
substitutions, R14C [66], P23T [64,67], P23S [68], A35P
[22], R36S [69], and R58H [58] and another causing
truncation of the protein, W156X [64], give rise to
several different forms of cataract.
CRYGS
This gene shares the three-exon structure of other
γ-crystallin encoding genes; although at 6 kb, it is some-
what larger than typical. Indeed, the longer, first intron
of the human gene appears to contain a transcriptionally
active region, of unknown function, and rare, probably
non-functional, alternatively splice products of the gene
that incorporate part of this sequence have been noted
[70]. In contrast to the genes of the Chr 2 cluster,
CRYGS is well-conserved in evolution and is expressed
at high levels in human lens, particularly in adult in the
cortical region [36,70].
Cataractogenic mutations The distribution of expres-
sion in the lens is consistent with the progressive
polymorphic cortical cataract caused by the G18V sub-
stitution of a key residue of the Greek-key motif [71].
Another mutant, D25G has also been reported [22].
CRYGN
This is another gene with orthologs throughout verte-
brates [28]. Its gene structure resembles an evolutionary
intermediate between those that code for the β- and
γ-crystallins, with the N-terminal domain of the protein
coded in one uninterrupted exon, as in a γ-crystallin
gene, and the two motifs of the C-terminal domain
encoded in separate exons, as in a β-crystallin gene
(Figure 1). The gene is expressed at low levels in mouse
lens and other parts of the eye [28], but human CRYGN
appears to be non-functional. No cDNAs with the
expected splice pattern for a full ORF have ever been
detected, although some rare transcripts, apparently
both sense and antisense, have been observed in differ-
ent, non-lens cDNA libraries. These may relate to the
presence of a microRNA gene, miR-3907, in the third in-
tron of the gene. Human CRYGN is probably a pseudo-
gene that has been deactivated relatively recently in
evolution. However, the gene is represented in builds of
the human genome and even has a RefSeq entry. The
gene is 10 kb long and is located on Chr 7.
CYRGGP
In addition to the full-sized genes for γ-crystallins with
orthologs in other mammals, the human genome con-
tains an isolated fragment of sequence similar to that en-
coding γD motif 2 in CRYGD, apparently associated with
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HUGO designation as CRYGGP, but it is not represented
in most genome browsers. The name is problematic as it
suggests that, by analogy to CRYGEP and CRYGFP, it is
a formerly functional gene that has been silenced in the
human lineage, whereas it appears to be merely a trans-
located remnant.
Superfamily relationships The βγ-crystallin superfamily
contains many members in prokaryotes and eukaryotes.
In the human genome, the major non-crystallin mem-
bers of the superfamily are absent in melanoma 1
(AIM1) (also known as CRYBG1, for ‘βγ crystallin do-
main containing 1’), the related AIM1-like protein
(AIMIL or CRYBG2) and CRYBG3. The proteins contain
six βγ-crystallin-like domains encoded in exons arranged
like those in β-crystallin genes [72,73]. Since the proteins
encoded by these genes do not serve as crystallins, using
the term to describe them is potentially confusing, at
least from a functional point of view and the current no-
menclature is inconsistent. The names AIM1, AIML1,
and AIML2 would better describe their family relation-
ship. However, there is potential confusion here too. The
acronym ‘AIM1’ has been used for different genes
(SLC45A2, AURKB), while AIM2 is the HGNC approved
designation for another gene unrelated to AIM1.
AIM1 spans almost 60 kb on human Chr 6. It consists
of 20 exons, 12 of which code for βγ-crystallin motifs,
corresponding to six domains possibly arranged effect-
ively as a β-crystallin trimer [72]. Additional short exons
in this region code for linkers between the two-domain
β-crystallin regions. This region must have arisen by
successive duplication of an ancestral, β-crystallin-like
gene. The AIM1 protein also contains a long, proline-
rich N-terminal region (over 1,000 residues) with no
clear structural relationships and a C-terminal ricin-like
trefoil domain. Interestingly, another connection be-
tween βγ domains and a trefoil domain has been
observed in a protein discovered in skin secretions of a
frog (Bombina maxima). The so-called βγ-CAT [74] is a
dimer of a βγ-crystallin superfamily member and a tre-
foil domain protein. Although AIM1 is not a crystallin,
it is expressed at moderately high levels in a human
cornea cDNA library [75].
The AIM1L gene covers 32 kb on Chr 1, and CRYBG3
covers 123 kb on Chr 3. Both these genes have similar
exon/domain structures to AIM1, although CRYBG3
appears to have two additional coding 50 exons.
Functional implications Members of the βγ-crystallin
superfamily are quite diverse, and no single functional
role is clear. However, some of them seem to be asso-
ciated with cellular architecture. AIM1 expression is
associated with changes in appearance and reduction ofmalignancy in melanoma cells [76], while another rela-
tive, EDSP/Ep36, is associated with plasma membrane in
developing Cynops amphibian embryos [77,78]. Recently,
it has been shown that mouse γS-crystallin associates
with F-actin in the lens and can stabilize F-actin in vitro
[79]. While not reaching the level of chaperone activity,
it is possible that the characteristic βγ-crystallin protein
domain has a generalized role in shepherding large
oligomers (like cytoskeleton and other crystallins) and
preventing aggregation.
BHMT and other ‘enzyme crystallins’
As described above, some major crystallins are more or
less specialized for their role in lens and may have no
role, or at least only a minor role, in other tissues. How-
ever, during evolution, the molecular composition of the
lens has adapted in response to changing environmental
demands. In the human lineage, this has involved the
loss of γ-crystallins, the loss of the alternative ‘insert’
exon of CRYAA, and (probably) decreased expression of
CRYBA2, while genes for other non-crystallin proteins,
such as LGSN/lengsin (exon loss) [80] and LIM2/MP19
(exon extension) [36], have also been affected. In many
species, particularly when expression of γ-crystallins has
been reduced, existing, stable proteins with the needed
properties have been recruited to a new role as a crystal-
lin through increased expression in lens. These are usu-
ally enzymes, so that, for example, in many birds and
crocodiles the enzyme lactate dehydrogenase B became
ε-crystallin in the lens while retaining its expression and
function as an enzyme [81]. The same process has
occurred in primates. Probably to compensate for, or
to replace absent or down-regulated γ-crystallins, the
developing primate lens expresses high levels of the
enzyme BHMT [82]. In a human fetal lens cDNA li-
brary, BHMT is the most abundantly expressed gene
(http://neibank.nei.nih.gov/cgi-bin/showDataTable.cgi?
lib=NbLib0012). Thus, BHMT should certainly qualify
as a human crystallin gene; however, the proposed name
ψ-crystallin [82] has not been widely used perhaps be-
cause of the potential confusion with the symbol for
pseudogene. So far, no genetic cataract has been asso-
ciated with BHMT/ψ-crystallin, but it is certainly a
candidate worth considering for congenital nuclear
cataract, possibly microphthalmia. BHMT, as expressed
in many tissues, is an eight exon, 20-kb gene on Chr 5
separated by about 20 kb from the related BHMT2.
The term crystallin may also arise in connection with
other human genes whose orthologs in other species
serve as crystallins. CRYM is the human ortholog of
the gene that encodes μ-crystallin in many marsupials
[83-85]. In humans, CRYM is expressed quite abundantly
in retina and inner ear, where mutants are associated
with deafness [86], and cDNAs for this gene are found
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does not rise to ‘crystallin-levels’ of expression in lens.
μ-crystallin belongs to an enzyme superfamily and has
been identified as a ketamine reductase and also as a
thyroid-hormone-binding protein [84,87,88].
CRYZ is the human ortholog of the gene that codes
for ζ-crystallin in hystricomorph rodents (such as guinea
pig) and camels [89]. The protein is a quinone oxidore-
ductase [90]which is not expressed at high levels in
human lens, although it is moderately abundant in a
human cornea cDNA library [75]. A related gene is
designated as CRYZL1, and there is also a pseudogene
copy, CRYZP1.
CRYL is the human ortholog of the gene that codes
for λ-crystallin in lagomorphs (rabbits, hares, pikas) [91].
λ-crystallin is related to hydroxyacyl coenzyme A dehy-
drogenases but does not serve as a crystallin in humans.
The enzyme α-enolase (ENO1) is also sometimes
referred to as τ-crystallin (see OMIM: *172430) because
of its role as a crystallin in several non-mammalian spe-
cies [92], but, although quite abundant as an enzyme in
lens, it does not pass the (rather subjective) test to
qualify as a human crystallin.
Lens-preferred gene expression
Although proteins of very different superfamilies act as
crystallins in the lens, they all acquired this role through
increased gene expression in the lens. Some crystallins
are essentially tissue-specific, most have some level of
expression in other parts of the eye, while others have a
completely separate machinery of expression in non-
ocular tissues. The basis for lens-expression is similar
for many, if not all, crystallins. The gene promoter con-
tains response elements for some key transcription fac-
tors essential for normal lens development. Prominent
among these are factors such as Pax6, c-Maf, Sox2,
Prox1, and Six3 [93,94]. In many crystallin gene promo-
ters, elements for lens and non-lens expression are com-
bined in the same 50 region. However, one of the more
recently recruited enzyme crystallins, ζ-crystallin of the
guinea pig (C. porcellus), illustrates dual promoter func-
tionality quite nicely with an alternative promoter
dependent on Pax6 and Maf elements, driving lens-
specific expression [95].
Conclusion
The human genome contains genes corresponding to all
the major crystallins that are expressed in mouse and
most other mammals. However, some of these (CRYGEP,
CRYGFP, and CRYGN) are designated or likely pseudo-
genes in humans, while other genes have reduced ex-
pression compared with mouse. The genes for human
crystallins encode proteins which belong to two unre-
lated superfamilies, the α-crystallin/sHSP superfamilyand the βγ-crystallin superfamily (which in the human
genome contains three genes for the AIM1 family). An-
cestral members of these superfamilies were recruited to
serve as crystallins in the earliest vertebrate lens, pre-
sumably because they could form and maintain the
transparent, refractive medium needed to focus light.
Humans also have another gene that has been recruited
to a crystallin role more recently in evolution. The en-
zyme BHMT has very high expression in fetal lens where
it may serve to replace those γ-crystallins whose expres-
sion has been reduced or eliminated. Indeed, crystallins
have provided important early insights into the ways
proteins can have multiple functions and can be adapted
during evolution [4]. As might be expected, crystallins
are implicated in many inherited cataracts, but in
addition, due to their other roles as stress proteins or
enzymes, proteins that serve as crystallins also show up
unexpectedly in a number of disease states in eye and
other tissues.
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